ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA01 | G | Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg | 9286 | 101017/1 | LOSARTAN/HYDROCHLOROTHIAZIDE ARROW LAB | 30 | Tablet, film coated | Oral | Darapharma S.A.L. | APL Swift Services (Malta) Limited | Malta | 470,345 L.L | 23.08 | A1 | Arrow Génériques | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C09DA01 | B | Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg | 6847 | 97888/12 | HYZAAR | 30 | Tablet | Oral | Droguerie de l'Union | Algorithm S.A.L. under license from Organon LLC 30 Hudson Street, Jersey City, NJ, USA | Lebanon | 1,523,022 L.L | 23.08 | B | 2/5/2024 | 0 | |||
C09DA01 | G | Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg | 4645 | 195019/04 | LOSANET-H | 30 | Tablet | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 395,474 L.L | 23.08 | A1 | 2/5/2024 | 0 | |||
C09DA01 | G | Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg | 10945 | 154220/1 | LOSARTAN/HYDROCHLOROTHIAZIDE BGR | 30 | Tablet, coated | Oral | Commercial and Trading Ressources SAL (CTR) | Laboratorios Liconsa SA | Spain | 439,436 L.L | 23.08 | A1 | Laboratoires Biogaran | France | 2/5/2024 | 0 | |
C09DA01 | G | Losartan potassium - 50mg, Hydrochlorothiazide - 12.5mg | 7174 | 97396/12 | LOSARTAN/HYDROCHLOROTHIAZIDE REMEDICA | 30 | Tablet, film coated | Oral | Droguerie Columbus | Remedica Ltd | Cyprus | 635,638 L.L | 23.08 | A1 | Remedica Ltd | Cyprus | 2/5/2024 | 0 |